|
Headlines |
Dr. Nigel Smith appointed as next Director of TRIUMF |
12 February 2021 |
Dr. Smith will begin his 5-year term as TRIUMF Director on May 17, 2021. |
|
|
Research Highlights |
Hunting with the BeEST: PRL paper establishes new boundaries in search for sterile neutrinos |
20 January 2021 |
An international team that includes researchers from TRIUMF has published new measurements for the exclusion limits for sterile neutrinos. |
|
|
Research Highlights |
New paper provides novel predictions for nuclear driplines up to iron |
13 January 2021 |
A new paper published by TRIUMF Theory Department scientist Jason Holt and colleagues from the University of Washington and Germany has provided first-principles predictions of which isotopes can and can’t exist for elements from helium to iron. |
|
|
Awards & Honours |
New Order of Canada appointments recognize TRIUMF BOM community members |
12 January 2021 |
On December 30th, 2020, Her Excellency the Right Honourable Julie Payette, Governor General of Canada announced 114 new appointments to the Order of Canada, including the recognition of two distinguished individuals from TRIUMF's Board of Management community. |
|
|
Research Highlights |
Initial beam through CANREB brings first glimpse of new era of TRIUMF science |
18 December 2020 |
TRIUMF scientists and engineers achieved a major milestone for the Advanced Rare Isotope Laboratory (ARIEL), maneuvering for the first time a radioactive isotope beam through ARIEL's CANREB facility and into the ISAC-II experimental hall. |
|
|
Headlines |
Cyclotron-produced technetium-99m approved by Health Canada |
17 December 2020 |
Health Canada has approved cyclotron-produced technetium-99m, greenlighting the made-in-Canada technology for national implementation and opening the door to a greener, more reliable way to make the most commonly used medical isotope. |
|
|
Headlines |
TRIUMF strikes landmark isotope deal to expand access to actinium-225 |
16 December 2020 |
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225, a valuable but scarce radioisotope with tremendous promise as a cancer treatment. |
|
|
Current Events |
TRIUMF welcomes new Chief Information Officer Shari Wallace |
14 December 2020 |
TRIUMF is pleased to welcome Ms. Shari Wallace as its new Chief Information Officer (CIO) |
|
|
Current Events |
A message from the TRIUMF Board of Management: Announcement of Interim Director |
10 December 2020 |
An important message from the TRIUMF Board of Management regarding the appointment of an interim TRIUMF Director |
|
|
Headlines |
A message from the TRIUMF Board of Management: Incorporation |
08 December 2020 |
On December 4, 2020, the TRIUMF Board of Management substantially approved the agreements required for the incorporation of TRIUMF. Read more here. |
|
